Gene · 8200
Papers2,199
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,199
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Energy Trade-off and 4 Extreme Human Body Types. | J Clin Endocrinol Metab | 2023 | 36413496 | PubTator, text mining | PubMed |
| Cell-scaffold interactions in tissue engineering for oral and craniofacial reconstruction. | Bioact Mater | 2023 | 36406245 | PubTator, text mining | PubMed |
| Genetic risk of osteoarthritis operates during human skeletogenesis. | Hum Mol Genet | 2023 | 36209419 | PubTator, text mining | PubMed |
| The Role of Cartilage Stem/Progenitor Cells in Cartilage Repair in Osteoarthritis. | Curr Stem Cell Res Ther | 2023 | 36201278 | PubTator, text mining | PubMed |
| Biomaterials and tissue engineering approaches using glycosaminoglycans for tissue repair: Lessons learned from the native extracellular matrix. | Acta Biomater | 2023 | 36182056 | PubTator, text mining | PubMed |
| An esterase-responsive ibuprofen nano-micelle pre-modified embryo derived nucleus pulposus progenitor cells promote the regeneration of intervertebral disc degeneration. | Bioact Mater | 2023 | 36017070 | PubTator, text mining | PubMed |
| Circ_0099630 Participates in SPRY1-Mediated Repression in Periodontitis. | Int Dent J | 2023 | 35933226 | PubTator, text mining | PubMed |
| Progress and prospect of technical and regulatory challenges on tissue-engineered cartilage as therapeutic combination product. | Bioact Mater | 2023 | 35846847 | PubTator, text mining | PubMed |
| Conditioned serum in vitro treatment of chondrocyte pellets and osteoarthritic explants. | Equine Vet J | 2023 | 35514185 | PubTator, text mining | PubMed |
| Patterns and Persistence of Perioperative Plasma and Cerebrospinal Fluid Neuroinflammatory Protein Biomarkers After Elective Orthopedic Surgery Using SOMAscan. | Anesth Analg | 2023 | 35389379 | PubTator, text mining | PubMed |
| Research progress on exosomal proteins as diagnostic markers of gastric cancer (review article). | Clin Exp Med | 2023 | 35066729 | PubTator, text mining | PubMed |
| Osteoarthritis - Insights From Recent Research. | J Rheum Dis | 2022 | 37475969 | PubTator, text mining | PubMed |
| Identification of pathological-related and diagnostic potential circular RNAs in Stanford type A aortic dissection. | Front Cardiovasc Med | 2022 | 36712253 | PubTator, text mining | PubMed |
| Morroniside ameliorates inflammatory skeletal muscle atrophy via inhibiting canonical and non-canonical NF-κB and regulating protein synthesis/degradation. | Front Pharmacol | 2022 | 36618945 | PubTator, text mining | PubMed |
| Age- and Stage-Dependent Prostate Cancer Aggressiveness Associated with Differential Notch Signaling. | Int J Mol Sci | 2022 | 36613607 | PubTator, text mining | PubMed |
| Relationship between asporin and extracellular matrix behavior: A literature review. | Medicine (Baltimore) | 2022 | 36595867 | PubTator, text mining | PubMed |
| Maintenance of methylation profile in imprinting control regions in human induced pluripotent stem cells. | Clin Epigenetics | 2022 | 36578048 | PubTator, text mining | PubMed |
| Research progress on the mechanism of interleukin-1β on epiphyseal plate chondrocytes. | Eur J Med Res | 2022 | 36575508 | PubTator, text mining | PubMed |
| CMTM7 recognizes an immune-hot tumor microenvironment and predicts therapeutic response of immunotherapy in breast cancer well. | Front Genet | 2022 | 36568362 | PubTator, text mining | PubMed |
| The potential mechanisms and application prospects of non-coding RNAs in intervertebral disc degeneration. | Front Endocrinol (Lausanne) | 2022 | 36568075 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8200/papers?page=17